YOLFTbeta
CorMedix Inc

CorMedix Inc

CRMD · NASDAQ · Healthcare / Biotechnology

4.66USD-0.18 (-3.72%)

Price History

Full chart

Market Stats

Previous Close4.84
Open4.88
Day Range4.65 – 5.06
52-Week Range6.13 – 13.02
Volume2.39M
Market Cap605.63M
P/E (TTM)3.52
Forward P/E46.51
EPS2.21
Dividend Yield0.00%
Beta1.50
50-Day Avg7.91
200-Day Avg8.12

About

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Joseph Todisco MBA
  • Employees191
  • Headquarters389 Interpace Pkwy, Parsippany, NJ, United States, 07054, USA
  • Websitehttps://cormedix.com

Leadership

  • Mr. Joseph Todisco MBACEO & Chairman of the Board of Directors · b. 1976
  • Ms. Elizabeth Masson-Hurlburt B.A.Executive VP and Chief Operating & Commercial Officer · b. 1979
  • Ms. Kaufman Beth Zelnick Esq.EVP, Chief Legal and Compliance Officer & Corporate Secretary · b. 1961
  • Ms. Susan BlumEVP & Chief Financial Officer · b. 1973
  • Ms. Beth SteinbrennerSVP & Chief Human Resource Officer
  • Dr. Matthew T. David M.D.EVP & Chief Business Officer · b. 1978
  • Donna UcciSenior VP & Head of Global Quality
  • Dr. Tushar MukherjeeSenior VP & Head of Technical Operations
  • Dr. Peter Sullivan BCOP, Pharm.D.Senior Vice President of Market Access
  • Mr. Jared L. Crandon Pharm.D.Executive Director of Clinical Portfolio Management

Financials

Income Statement

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---002.00K189.27K210.13K224.10K329.33K429.80K283.27K239.23K190.94K65.41K043.47M311.71M
Growth (%)------+9363.70%+11.02%+6.65%+46.95%+30.51%-34.09%-15.55%-20.19%-65.74%-100.00%-+617.03%
Cost of Revenue1.04M--00201.60K445.80K318.72K366.67K114.96K396.79K373.23K204.85K148.94K3.73K205.56K3.19M35.96M
Gross Profit-1.04M--00-199.60K-256.52K-108.59K-142.57K214.36K33.01K-89.97K34.38K42.00K61.67K-205.56K40.28M275.75M
Gross Margin------9980.20%-135.53%-51.68%-63.62%65.09%7.68%-31.76%14.37%22.00%94.29%-92.66%88.46%
Operating Expense3.77M--7.25M3.04M4.72M8.65M16.55M24.62M33.14M26.90M20.92M27.26M29.48M30.69M48.75M62.64M125.61M
Operating Income-4.82M-6.06M-8.51M-7.25M-3.04M-4.92M-8.90M-16.65M-24.76M-32.92M-26.86M-21.01M-27.22M-29.44M-30.62M-48.96M-22.36M150.14M
Operating Margin------245769.75%-4703.30%-7925.56%-11048.80%-9997.39%-6250.44%-7416.31%-11378.44%-15417.51%-46819.91%--51.43%48.17%
EBITDA-3.75M-6.04M-8.47M-7.19M-3.04M-7.68M-20.44M-18.17M-24.62M-32.97M-26.75M-20.93M-27.02M-29.38M-30.05M-46.23M-18.98M167.78M
EBITDA Margin------384177.40%-10797.18%-8646.31%-10985.04%-10012.25%-6224.69%-7390.44%-11294.67%-15385.10%-45945.10%--43.66%53.83%
Net Income-9.00M-8.12M-10.91M-6.71M-3.43M-9.13M-20.45M-18.19M-24.64M-33.01M-26.83M-16.43M-22.03M-28.21M-29.70M-46.34M-17.93M163.06M
Net Income Margin------456654.90%-10806.25%-8655.37%-10996.46%-10023.45%-6242.40%-5801.29%-9207.70%-14774.70%-45409.90%--41.24%52.31%
R&D3.08M4.89M5.49M4.10M1.19M1.23M1.32M6.28M15.74M24.49M18.82M11.05M13.38M13.13M10.68M13.16M3.94M19.33M
R&D as % of Total Revenue-----61343.70%696.73%2989.49%7021.40%7435.20%4379.39%3901.95%5591.75%6878.21%16327.59%-9.07%6.20%
Interest Expense4.21M2.07M3.09M12.04K382.94K1.44M2.09K3.96K1.31K5.62K1.87K787.49K33.23K15.94K26.52K34.30K36.41K2.78M
Interest Expense % of Total Revenue-----72219.30%1.10%1.89%0.58%1.71%0.44%278.00%13.89%8.35%40.54%-0.08%0.89%

Balance Sheet

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.62M2.23M8.85M2.56M1.15M2.97M5.10M37.10M21.91M13.45M18.83M29.48M49.31M68.95M62.04M82.06M118.85M826.14M
Total Liabilities13.65M16.93M1.59M1.32M1.63M6.99M1.46M3.09M4.09M6.26M13.89M5.83M5.09M6.15M6.98M11.92M34.19M420.83M
Total Equity-12.03M-14.71M7.26M1.24M-475.38K-4.02M3.63M34.01M17.81M-152.17M-178.99M-195.42M44.22M62.80M55.06M70.14M84.66M405.31M
Cash1.38M1.51M8.28M1.99M835.47K2.37M4.34M11.82M8.06M10.38M17.62M16.53M41.91M53.32M43.37M43.64M40.65M145.82M
Total Debt11.65M13.77M--269.75K-----6.13M4.69K1.03M923.80K802.43K667.63K517.01K148.91M
Net Debt10.27M12.26M-8.28M-1.99M-565.73K-2.37M-4.34M-11.82M-8.06M-10.38M-11.50M-16.52M-40.87M-52.39M-42.57M-42.98M-40.13M3.09M

Cash Flow

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.11M-2.15M-3.67M-6.30M-2.28M-3.62M-6.32M-12.53M-22.27M-28.59M-23.70M-15.05M-21.97M-21.16M-24.36M-38.41M-50.62M175.05M
Investing Cash Flow---10.36K-1.63K0-35.68K-25.40K-23.61M11.42M10.36M1.56M-12.02M7.43M-9.13M-3.71M-17.06M21.23M-308.43M
Financing Cash Flow2.96M2.27M10.46M23.86M1.13M5.20M8.36M43.63M7.09M20.52M29.40M25.80M40.10M41.76M17.90M55.92M26.32M238.45M
Capital Expenditure2010.36K1.63K035.68K25.40K15.45K58.72K151.99K48.89K36.57K112.64K1.43M219.36K327.30K116.00K2.26M
Free Cash Flow-4.11M-2.15M-3.68M-6.30M-2.28M-3.65M-6.35M-12.54M-22.32M-28.74M-23.75M-15.09M-22.08M-22.58M-24.58M-38.74M-50.73M172.79M
Dividends Paid---00384.31K0000--------
FCF to OCF100.00%100.00%100.28%100.03%100.00%100.99%100.40%100.12%100.26%100.53%100.21%100.24%100.51%106.74%100.90%100.85%100.23%98.71%
Dividend Paid to FCF---0.00%0.00%-10.52%0.00%0.00%0.00%0.00%--------

Earnings

Report DateAug 12, 2010Nov 9, 2010Mar 14, 2011May 10, 2011Aug 9, 2011Nov 10, 2011Mar 12, 2012May 8, 2012Aug 7, 2012Nov 9, 2012Mar 28, 2013May 16, 2013Aug 15, 2013Nov 20, 2013May 15, 2014Aug 14, 2014Nov 13, 2014Mar 12, 2015May 7, 2015Aug 6, 2015Nov 12, 2015Mar 15, 2016May 10, 2016Aug 4, 2016Nov 9, 2016Mar 16, 2017May 10, 2017Aug 9, 2017Nov 9, 2017Mar 19, 2018May 15, 2018Aug 14, 2018Nov 15, 2018Mar 14, 2019May 13, 2019Aug 13, 2019Nov 14, 2019Mar 16, 2020May 11, 2020Aug 10, 2020Nov 5, 2020Mar 30, 2021May 13, 2021Aug 12, 2021Nov 9, 2021Mar 29, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Mar 30, 2023May 15, 2023Aug 8, 2023Nov 14, 2023Mar 12, 2024May 9, 2024Aug 14, 2024Oct 30, 2024Mar 10, 2025May 6, 2025Aug 7, 2025Nov 12, 2025Mar 31, 2026May 14, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate-0.90-0.90--0.95-1.00-1.05----------0.62-0.50-0.57-0.47-0.65-0.55-0.80-0.47-0.55-0.75-1.07-0.72-0.80-0.65-0.60-0.50-0.50-0.30-0.40-0.28-0.21-0.25-0.24-0.23-0.24-0.25-0.22-0.18-0.19-0.18-0.23-0.22-0.21-0.23-0.19-0.20-0.24-0.21-0.20-0.28-0.25-0.100.140.250.200.630.740.330.26-0.05
EPS Actual-0.50-0.60-0.79-0.85-1.10-1.150.15-0.40-0.27-0.31-0.52-0.68-0.75-0.89-4.34-0.44-1.01-0.45-1.15-0.65-0.70-0.50-0.60-0.65-1.15-0.80-0.95-0.67-0.66-0.77-0.70-0.50-0.550.10-0.22-0.24-0.22-0.21-0.21-0.14-0.22-0.19-0.20-0.12-0.22-0.20-0.18-0.19-0.17-0.20-0.24-0.25-0.17-0.26-0.25-0.25-0.050.220.300.281.410.160.350.29-
Surprise44.44%33.33%-10.53%-10.00%-9.52%---------29.03%-102.00%21.05%-144.68%0.00%-27.27%37.50%-27.66%-18.18%-53.33%25.23%-31.94%16.25%-1.54%-28.33%-40.00%0.00%-83.33%125.00%21.43%-14.29%12.00%12.50%8.70%41.67%12.00%13.64%-11.11%36.84%-22.22%13.04%18.18%9.52%26.09%-5.26%-20.00%-4.17%19.05%-30.00%10.71%0.00%50.00%57.14%20.00%40.00%123.81%-78.24%6.06%11.54%-
TimingAfter-hoursPre-market-Pre-marketPre-marketAfter-hours---------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap605.63M
Enterprise Value487.07M
Trailing P/E3.52
Forward P/E46.51
PEG Ratio0.00
Price / Sales1.31
Price / Book1.30
EPS2.21
Book Value5.93
Revenue (TTM)462.25M
Gross Profit (TTM)417.00M
EBITDA262.55M
Profit Margin40.49%
Operating Margin42.10%
Return on Equity54.93%
Return on Assets24.56%
Shares Outstanding77.94M
Shares Float65.89M
Beta1.50
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 6 analystsTarget 15.33
  • Strong Buy
    3
  • Buy
    3

Ownership Breakdown

Institutions
58.07%
Insiders
7.61%
Retail / Other
34.32%

Top Institutional Holders

  • Deep Track Capital, LP
    6.27M8.05%
  • BlackRock Inc
    5.97M7.66%
  • Vanguard Capital Management, LLC
    3.13M4.02%
  • State Street Corp
    2.19M2.81%
  • Royce & Associates, LP
    1.89M2.42%
  • Geode Capital Management, LLC
    1.82M2.33%
  • UBS Group AG
    1.54M1.97%
  • Oberweis Asset Management Inc
    1.32M1.70%
  • Alyeska Investment Group, L.P.
    850.00K1.09%
  • Vanguard Portfolio Management, LLC
    742.57K0.95%
  • Northern Trust Corp
    637.68K0.82%
  • Charles Schwab Investment Management Inc
    602.97K0.77%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.23M2.86%
  • iShares Russell 2000 ETF
    1.91M2.45%
  • Avantis US Small Cap Value ETF
    1.52M1.95%
  • Oberweis Micro-Cap
    1.28M1.64%
  • Fidelity Small Cap Index
    809.46K1.04%
  • State Street® SPDR® S&P® PhrmctlsETF
    718.64K0.92%
  • iShares Russell 2000 Value ETF
    695.91K0.89%
  • Pacer US Small Cap Cash Cows 100 ETF
    633.98K0.81%

Stock Splits

  • Mar 26, 20191:5